Table 1.
Time after infection | Spleen | Liver | Lung | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
aly/aly | aly/+ | aly/aly | aly/+ | aly/aly | aly/+ | |||||||
h | ||||||||||||
12 | <DL* ‡ | 3.7 ± 0.6* | 3.2 ± 0.2 | 3.3 ± 0.5 | <DL | <DL | ||||||
24 | 3.7 ± 0.7* | 6.6 ± 0.1* | 3.5 ± 0.4 | 3.9 ± 0.4 | <DL | <DL | ||||||
48 | 6.0 ± 0.3* | 7.8 ± 0.2* | 4.3 ± 0.3 | 3.4 ± 0.7 | 4.3 ± 0.3* | 3.3 ± 0.2* | ||||||
96 | 6.6 ± 0.1 | 6.4 ± 0.1 | 5.4 ± 0.3* | 4.6 ± 0.3* | 5.6 ± 0.2* | 4.6 ± 0.3* |
Mice were infected with 104 PFU LCMV-WE intravenously. At the indicated time points after infection mice were killed and virus titers were determined in different organs. Values are given as log10(PFU LCMV/g organ) ± SD of 3–4 mice/experimental group.
P <0.01, significant difference of LCMV titers between aly/aly and aly/+ mice (Student's t test).
DL, detection limit of the assay (spleen, 2.0; liver, 3.0; lung, 2.5). Representative data of one out of three comparable experiments are shown.